METTL3 Promotes Cutaneous T-Cell Lymphoma Progression by Regulating ARHGEF12 Expression
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26083640 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Lu Gan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing 210042, China. Hauptthemen laut MEDLINE: Methyltransferases, Gene Expression Regulation, Neoplastic, Lymphoma, T-Cell, Cutaneous, Rho Guanine Nucleotide Exchange Factors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Provincial Natural Science Foundation, CAMS Innovation Fund for Medical Sciences and Clinical Translational Project, the Natural Fund of Jiangsu Province.
Abstract (Originalsprache)
Recent studies have identified N6-methyladenosine (m6A) RNA methylation as a key regulatory mechanism in tumor progression. This study aimed to elucidate the biological function and clinical relevance of the m6A methyltransferase METTL3 in cutaneous T-cell lymphoma (CTCL). Our findings demonstrated that METTL3 expression is upregulated in CTCL, and its knockdown suppresses CTCL progression. Mechanistically, the downregulation of METTL3-mediated m6A modification on ARHGEF12 mRNA accelerated its degradation, a process that is closely associated with tumor behaviors. These results suggest that METTL3 may serve as a potential therapeutic target in CTCL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing 210042, China.
ORCID-Profile: Yingqi Kong
Förderung
- Jiangsu Provincial Natural Science Foundation
- CAMS Innovation Fund for Medical Sciences and Clinical Translational Project
- the Natural Fund of Jiangsu Province
Zitieren
APA
Gan, L., Kong, Y., Shi, H., Zhang, C., Tian, C., & Chen, H. (2025). METTL3 Promotes Cutaneous T-Cell Lymphoma Progression by Regulating ARHGEF12 Expression. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26083640
Vancouver
Gan L, Kong Y, Shi H, Zhang C, Tian C, Chen H. METTL3 Promotes Cutaneous T-Cell Lymphoma Progression by Regulating ARHGEF12 Expression. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26083640
BibTeX
@article{Gan2025,
author = {Gan, Lu and Kong, Yingqi and Shi, Haoze and Zhang, Congcong and Tian, Cuicui and Chen, Hao},
title = {METTL3 Promotes Cutaneous T-Cell Lymphoma Progression by Regulating ARHGEF12 Expression},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26083640}
}
EUVIMED